MARKET

MNK

MNK

Malinckrodt
NYSE

Real-time Quotes | Nasdaq Last Sale

2.545
+0.105
+4.30%
Opening 11:58 09/23 EDT
OPEN
2.820
PREV CLOSE
2.440
HIGH
2.970
LOW
2.500
VOLUME
12.04M
TURNOVER
--
52 WEEK HIGH
32.34
52 WEEK LOW
1.430
MARKET CAP
213.80M
P/E (TTM)
-0.0613
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MNK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 14 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

MNK News

  • Mallinckrodt May See One More Trading Bounce Before Bankruptcy
  • Seeking Alpha - Article.37m ago
  • Mallinckrodt Stock Is Soaring Because Its News Is Good Enough to Forget Opioids for a Day
  • Barrons.com.44m ago
  • The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LB, MNK, JE and PS
  • GlobeNewswire.1h ago
  • Mallinckrodt Shares Rebound On Positive Late-Stage StrataGraft Results
  • Benzinga.1h ago

More

Industry

Pharmaceuticals
-0.15%
Pharmaceuticals & Medical Research
-0.18%

Hot Stocks

Name
Price
%Change

About MNK

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
More

Webull offers Mallinckrodt PLC (MNK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.